Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia

93Citations
Citations of this article
104Readers
Mendeley users who have this article in their library.

Abstract

We evaluated the published data for the incidence, characteristics and outcomes of patients with community-acquired pneumonia (CAP) due to methicillin-resistant Staphylococcus aureus (MRSA). The estimated incidence of MRSA CAP is 0.51-0.64 cases per 100,000. We identified 74 articles reporting data on 114 patients. Influenza like symptoms was reported in 41% of patients. Pneumonia improved in 59 (54.1%) out of 109 patients; 49 (44.5%) out of 110 patients died. The duration of hospitalisation was 38.1±24.9 and 8.3±11.7 days, respectively. The duration of intensive care unit (ICU) stay was 18.9±13.6 and 6.8±9.7 days, respectively. 76 strains carried the Panton-Valentine leukocidin gene. The univariate analysis showed that multi-organ failure (p<0.001), leukopenia (p<0.001), admission to ICU (p<0.001), mechanical ventilation (p<0.001), use of aminoglycosides after culture results (p<0.001), shock (p=0.001), acute respiratory distress syndrome (p=0.001), influenza like symptoms (p=0.008), disseminated intravascular coagulation (p=0.042) and rash (p=0.04) were the factors associated with death. Copyright©ERS Journals Ltd 2009.

Cite

CITATION STYLE

APA

Vardakas, K. Z., Matthaiou, D. K., & Falagas, M. E. (2009, November). Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. European Respiratory Journal. https://doi.org/10.1183/09031936.00041009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free